Syros Pharmaceuticals, Inc. Recorded Big Gain

Tue, Mar 18, 2025 at 07:49 PM

Syros Pharmaceuticals, Inc. (SYRS:NASDAQ) rocketted at $0.13, a gain of 49.2%. On Tue, Mar 18, 2025, SYRS:NASDAQ hit a New 2-Week Intraday High of $0.19. The stock got featured on our News Catalysts scanner on Tue, Mar 04, 2025 at 02:53 AM in the 'MISCELLANEOUS' category. From Tue, Mar 04, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Tue, Mar 11, 2025 at $0.3 with a volume of 695M+.

About Syros Pharmaceuticals, Inc. (SYRS:NASDAQ)

Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.

Top 10 Gainers:

Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
FST Corp. (KBSX:NASDAQ), 309.7%
Aditxt Inc. (ADTX:NASDAQ), 71.62%
Regencell Bioscience Holdings Limited (RGC:NASDAQ), 70.81%
Syros Pharmaceuticals, Inc. (SYRS:NASDAQ), 49.18%
Leishen Energy Holding Co. Ltd. (LSE:NASDAQ), 46.6%
Chijet Motor Company Inc. (CJET:NASDAQ), 39.66%
Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 34.78%
Park Ha Biological Technology Co. Ltd. (PHH:NASDAQ), 34.35%
OSR Holdings Inc. (OSRH:NASDAQ), 33.58%